Modern Optometry
Online/Digital
A resource for optometrists practicing at the top of their license. Medical eye care is the future of optometry and Modern Optometry is your go-to resource for navigating the evolution of the profession. This is a BMC Vision publication. Source
Actions
Media Outlet details
| Scope | N/A |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesEducating Patients on IOL Options
The ideal patient for an extended-depth-of-focus IOL wants the visual flexibility to drive, work on the computer, cook, play golf, play pickleball, and see the dashboard without constantly reaching for glasses. The ideal patient for a small-aperture IOL wants a more functional range of vision, but may not be an ideal candidate for multifocal optics due to optical imperfections from, for example, mild corneal irregularities.
The Value in Stay and Exit Interviews
Stay and exit interviews can be a valuable source of information when it comes to employee retention and, thus, practice prosperity. Here, I explain how, organized by each interview type and the value they pose. • Value to the Owner Stay interviews show what employees think you’re doing well and where there may be room for improvement. You can opt to conduct them every 3 to 6 months. If a concern is raised, be prepared to respond to it.
Are You Complying with the DSCSA?
Although the Drug Supply Chain Security Act (DSCSA) was passed 13 years ago and applies to eyecare practices, many remain in the dark regarding its effect on them, says the founder of a company that delivers readiness audits for regulated medical environments. “What the FDA wants is everyone to be good stewards of their part of the supply chain,” says James Strafuss, founder of the company Claritas Axis.
Establishing a Practical Collaborative Care Protocol
We recognize how crucial the health of the ocular surface is for improving the accuracy of biometry measurements and, ultimately, a patient’s long-term visual and ocular comfort outcomes. In the case of precataract surgery patients, we keep an eye out for glaucoma, as patients who have this condition may benefit from a minimally invasive glaucoma surgery during the procedure.
Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Younger practitioners hear stories about the days when cyclosporine was the only pharmaceutical option for dry eye disease, about the times optometrists had to haul heavy heating therapies in our cars between clinics, and about the era when Bruder masks were a cutting-edge technology. Luckily for today’s patients with dry eye and meibomian gland dysfunction (MGD), we have more options than ever—and many of them don’t require us to lift heavy machinery.
A Review on Identifying and Explaining Cataracts
A nuclear sclerotic cataract appears brown or yellow. Empathy and framing a cataract as an opportunity, not a burden, can be effective in communicating the diagnosis. While visual acuity must be documented for insurance coverage of the procedure, there is no magic number. The diagnosis of cataracts and, therefore, the journey toward surgery often begins in our chairs.
Metabolic Syndrome, GLP-1 Use, and NAION
Non-arteritic anterior ischemic optic neuropathy is characterized as unilateral sectoral disc edema, secondary to poor perfusion to the optic nerve, causing local ischemia. The condition is purely a diagnosis of exclusion, so arteritic anterior ischemic optic neuropathy must always be ruled out. Our patient’s medical history revealed significant metabolic dysregulation, strongly supporting the notion that metabolic syndrome was a major contributing factor to his NAION.
July/August 2026 ISSUE
You are now leaving Modern Optometry and going to a site run by another organization. Press cancel to remain on Modern Optometry. Press the link below or the continue button to keep going.
Employing Energy-Based Technology
Energy-based technologies have shown to be effective in treating dry eye disease associated with ocular rosacea and meibomian gland dysfunction and in creating periocular and periorbital cosmesis. Energy-based treatments are often complementary rather than mutually exclusive when it comes to aesthetic outcomes. There is a rising demand for noninvasive and minimally invasive aesthetic treatments. Energy-based technologies fall under this treatment umbrella.
Ocular Aesthetics for Diverse Populations
Beauty ideals, cultural norms, skin coloring, and patient expectations are not universal in our country, as it is comprised of a diverse population. Cosmetic concerns are often related to adnexal and ocular surface health. Ocular aesthetics should begin with function and build thoughtfully from there. Beauty ideals, cultural norms, skin coloring, and patient expectations are not universal in our country, as it is comprised of a diverse population.